Cheshire, UK -- (MARKET WIRE) -- 12/22/2005 -- Protherics PLC (“Protherics”), the biopharmaceutical company focused on critical care and oncology, announces the grant, under the Protherics PLC Long Term Incentive Plan, of the following options over 2p ordinary shares in the Company, on 21 December 2005: More...
